This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring both an aminopyrrolidine and a cyclopropyl group, makes it valuable in the development of drugs targeting the central nervous system (CNS). It is often employed in the creation of compounds that interact with neurotransmitter receptors, potentially aiding in the treatment of neurological disorders such as depression, anxiety, and schizophrenia. Additionally, its unique chemical framework allows for the exploration of novel therapeutic agents in medicinal chemistry research, particularly in the design of molecules with enhanced selectivity and efficacy.